Different properties of the bradycardia produced by neostigmine and edrophonium in the cat

Canadian Journal of Anaesthesia

Volumn 43, Issue 7, 1996, Pages 731-740

  Backman, Steven B ^a,c   Stein, Reuben D ^a,b   Blank, David W ^a   Collier, Brian ^b   Polosa, Canio ^a,b  

^a Royal Victoria Hospital   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

ANTAGONISTS, NEUROMUSCULAR RELAXANTS, edrophonium; bradycardia; HEART: arrhythmia; neostigmine

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; CHOLINERGIC RECEPTOR; EDROPHONIUM; GALLAMINE; GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; OTENZEPAD; PANCURONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CAT; CONTROLLED STUDY; DOSE RESPONSE; ELECTROSTIMULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART RATE; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; SINUS RHYTHM; VAGOTOMY; VAGUS NERVE;

EID: 0029768026     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017959     Document Type: Article

References (39)

1. Hill M. Death after neostigmine injection (Letter). BMJ 1949; 2: 601.
2. MacIntosh RR. Death following injection of neostigmine. BMJ 1949; 1: 852.
3. Backman SB, Bachoo M, Polosa C. Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine. J Pharm Exp Ther 1993; 265: 194-200.
4. Brehm G, Lindmar R, Löffelholz K. Inhibitory and excitatory muscarinic receptors modulating the release of acetylcholine from the postganglionic parasympathetic neuron of the chicken heart. Naunyn Schmiedebergs Arch Pharmacol 1992; 346: 375-82.
5. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds.).Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed New York: McGraw-Hill, 1996: 141-60.
6. Mitchelson F. Muscarinic receptor differentiation. Pharmacol Ther 1988; 37: 357-423.
7. Morris RB, Cronnelly R, Miller RD, Stanski DR, Fahey MR. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. Anesthesiology 1981; 54: 399-402.
8. Riker WF Jr, Wescoe WC. The direct action of prostigmine on skeletal muscle; its relationship to the choline esters. J Pharmacol Exp Ther 1946; 88: 58-66.
9. Pascoe JE. The effects of acetylcholine and other drugs on the isolated superior cervical ganglion. J Physiol 1956; 132: 242-55.
10. Long JP, Eckstein JW. Ganglionic actions of neostigmine methylsulfate. J Pharmacol Exp Ther 1961; 133: 216-22.
11. Mason DFJ. A ganglion stimulating action of neostigmine. Br J Pharmacol 1962; 18: 76-86.
12. Mason DFJ. Depolarizing action of neostigmine at an autonomic ganglion. Br J Pharmacol 1962; 18: 572-87.
13. Carlyle RF. The mode of action of neostigmine and physostigmine on the guinea-pig trachealis muscle. Br J Pharmacol 1963; 21: 137-49.
14. Takeshige C, Volle RL. Asynchronous postganglionic firing from the cat superior cervical sympathetic ganglion treated with neostigmine. Br J Pharmacol 1963; 20: 214-20.
15. Kostowski W, Gumutka W. Actions of neostigmine and physostigmine on sympathetic ganglia in the cat. International Journal of Neuropharmacology 1966; 5: 193-8.
16. Mihara S, Ikeda K, Nishi S. Muscarinic M2 receptors on cardiac ganglion neurons of the guinea-pig heart. Kurume Med J 1988; 35: 183-92.
17. Hoover DB, Baisden RH, Xi-Moy SX. Localization of muscarinic receptor mRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. Circ Res 1994; 75: 813-20.
18. 2 muscarinic receptors mediate excitation and inhibition of guinea-pig intracardiac neurons in culture. J Physiol 1990; 422: 463-80.
19. Dunlap J, Brown JH. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Mol Pharmacol 1983; 24: 15-22.
20. Brown JH, Wetzel GT, Dunlap J. Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors. J Pharm Exp Ther 1982; 223: 20-4.
21. Campbell GD, Edwards FR, Hirst GDS, O'Shea JE. Effects of vagal stimulation and applied acetylcholine on pacemaker potentials in the guinea-pig heart. J Physiol 1989; 415: 57-68.
22. De Wildt DJ, Oud PHJH, Porsius AJ. The inotropic and chronotropic effects of physostigmine and neostigmine on guinea-pig isolated atria. J Auton Pharmacol 1982; 2: 111-7.
23. Cronnelly R, Morris RB, Miller RD. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia. Anesthesiology 1982; 57: 261-6.
24. Fogdall RP, Miller RD. Antagonism of d-tubocurarine-and pancuronium- induced neuromuscular blockades by pyridostigmine in man. Anesthesiology 1973; 39: 504-9.
25. Backman, SB, Fox, GS, Stein, RD, Ralley, FE. Neostigmine decreases heart rate in heart transplant patients. Can J Anaesth 1996; 43: 373-8.
26. Backman SB, Ralley FE, Fox GS. Neostigmine produces bradycardia in a heart transplant patient. Anaesthesiology 1993; 78: 777-9.
27. Backman SB, Stein RD, Fox GS, Polosa C. Effect of edrophonium on heart rate in cardiac transplant patients and in the denervated cat heart. Can J Anaesth 1996; 43: (in press).
28. Ramamurthy S, Ylagan LB, Winnie AP. Glycopyrrolate as a substitute for atropine: a preliminary report. Anesth Analg 1971; 50: 732-6.
29. Mirakhur RK, Dundee JW, Clarke RSJ. Glycopyrrolate-neostigmine mixture for antagonism of neuromuscular block: comparison with atropine-neostigmine mixture. Br J Anaesth 1977; 49: 825-9.
30. Salem MG, Richardson JC, Meadows GA, Lamplugh G, Lai KM. Comparison between glycopyrrolate and atropine in a mixture with neostigmine for reversal of neuromuscular blockade. Br J Anaesth 1985; 57: 184-7.
31. Orduro KA. Glycopyrrolate methobromide. 2. Comparison with atropine sulphate in anaesthesia. Can Anaesth Soc J 1975; 22: 466-73.
32. Ostheimer GW. A comparison of glycopyrrolate and atropine during reversal of nondepolarizing neuromuscular block with neostigmine. Anesth Analg 1977; 56: 182-6.
33. Meyers EF, Tomeldan SA. Glycopyrrolate compared with atropine in prevention of the oculocardiac reflex during eye-muscle surgery. Anesthesiology 1979; 51: 350-2.
34. Mirakhur RK, Dundee JW, Jones CJ, Coppel DL, Clarke RSJ. Reversal of neuromuscular blockade: dose determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine. Anesth Analg 1981; 60: 557-62.
35. Abboud T, Raya J, Sadri S, Grobler N, Stine L, Miller F. Fetal and maternal cardiovascular effects of atropine and glycopyrrolate. Anesth Analg 1983; 62: 426-30.
36. Preiss D, Berguson P. Dose-response studies on glycopyrrolate and atropine in conscious cardiac patients. Br J Clin Pharmacol 1983; 16: 523-7.
37. Berger J, Gravenstein J, van der Aa J, Paulus L, Sabah-Maren E, McLaughlin G. Comparative potency of atropine sulphate and glycopyrrolate on heart rate in man. Eur J Anaesthesiol 1988; 5: 23-30.
38. Green DW, Bristow ASE, Fisher M. Comparison of i.v. glycopyrrolate and atropine in the prevention of bradycardia and arrhythmias following repeated doses of suxamethoniumin children. Br J Anaesth 1984; 56: 981-4.
39. Ali-Melkkila T, Kaila T, Antila K, Halkola L, Iisalo E. Effects of glycopyrrolate and atropine on heart rate variability. Acta Anaesthesiol Scand 1991; 35: 436-41.